Filing Details

Accession Number:
0001209191-17-025811
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-05 18:08:01
Reporting Period:
2016-04-01
Filing Date:
2017-04-05
Accepted Time:
2017-04-05 18:08:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576169 BenefitfocusInc. BNFT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1427813 P James Restivo 100 Benefitfocus Way
Charleston SC 29492
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-01 15,000 $0.00 51,401 No 4 A Direct
Common Stock Disposition 2017-04-03 2,192 $27.28 49,209 No 4 S Direct
Common Stock Disposition 2017-04-03 1 $28.15 49,208 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Performance Restricted Stock Units $0.00 2017-12-31 8,627 8,627 Direct
Common Stock Performance Restricted Stock Units $0.00 2018-04-01 2,822 2,822 Direct
Common Stock Performance Restricted Stock Units $0.00 2021-04-01 8,467 8,467 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-12-31 8,627 8,627 Direct
2018-04-01 2,822 2,822 Direct
2021-04-01 8,467 8,467 Direct
Footnotes
  1. Represents restricted stock units which vest in four equal annual installments beginning on April 1, 2017, subject to continued employment.
  2. This sale was executed in multiple trades at prices ranging from $27.15 to $28.00. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.
  3. Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSU is presented in the table. PRSUs vest upon the achievement of adjusted EBITDA and compounded annual revenue growth rate goals during the period of January 1, 2015 through December 31, 2017. Vesting of the target level PRSUs will accelerate upon death or disability in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.
  4. Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. A percentage of the PRSUs will vest upon the achievement of annual revenue goals and free cash flow goals, all subject to a minimum adjusted EBITDA level, during the period of January 1, 2017 through December 31, 2017. Vesting of the target level PRSUs will accelerate upon death or disability in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.
  5. Each PRSU represents a contingent right to receive one share of Issuer common stock. The maximum number of PRSUs is presented in the table. The PRSUs will vest upon the achievement of annual recurring revenue bookings percentage growth goals during the period of January 1, 2017 through December 31, 2017, such vesting to occur in four equal annual installments beginning on April 1, 2018, if the performance metrics are met. Vesting of the target level PRSUs will accelerate upon death or disability in an amount equal to the proportion of days in the performance period worked. Vesting of the target PRSUs may also accelerate in certain circumstances if there is a change in control of the Issuer during the performance period.